Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials

Pio Navarese, Eliano; Andreotti, Felicita; Schulze, Volker; Ko odziejczak, M.; Buffon, Antonino; A. Brouwer, Marc; Costa, Francesco; Kowalewski, Mariusz; Parati, Gianfranco; Y.H. Lip, Gregory; Kelm, Malte; Valgimigli, Marco

doi:10.1136/bmj.h1618

Public

Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials

Published in BMJ • Apr 16, 2015

Authors:

Eliano Pio Navarese

Felicita Andreotti

Volker Schulze

Abstract

OBJECTIVE: To assess the benefits and risks of short term (12 months) dual antiplatelet therapy (DAPT) versus standard 12 month therapy, following percutaneous coronary intervention with drug eluting stents. DESIGN: Meta-analysis of randomised controlled trials. DATA SOURCES: PubMed, Embase, Cumulat...

Subject

Medicine

Percutaneous coronary intervention

Internal medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!